WO2010141680A3 - Hedgehog pathway antagonists and methods of use - Google Patents
Hedgehog pathway antagonists and methods of use Download PDFInfo
- Publication number
- WO2010141680A3 WO2010141680A3 PCT/US2010/037200 US2010037200W WO2010141680A3 WO 2010141680 A3 WO2010141680 A3 WO 2010141680A3 US 2010037200 W US2010037200 W US 2010037200W WO 2010141680 A3 WO2010141680 A3 WO 2010141680A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- hedgehog pathway
- pathway antagonists
- pathway
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present disclosure provides for a compound, pharmaceutical preparations, kits and methods for the inhibition of the Hh pathway and the alleviation of cancer and developmental disorders associated with the Hh pathway.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18358709P | 2009-06-03 | 2009-06-03 | |
US61/183,587 | 2009-06-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010141680A2 WO2010141680A2 (en) | 2010-12-09 |
WO2010141680A3 true WO2010141680A3 (en) | 2011-03-31 |
Family
ID=43298500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/037200 WO2010141680A2 (en) | 2009-06-03 | 2010-06-03 | Hedgehog pathway antagonists and methods of use |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010141680A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102329277B (en) * | 2011-10-24 | 2013-08-07 | 海南霞迪药业有限公司 | Method for preparing Parecoxib |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060132615A (en) * | 2003-12-15 | 2006-12-21 | 니뽄 다바코 산교 가부시키가이샤 | Cyclopropane compounds and pharmaceutical use thereof |
WO2008124524A2 (en) * | 2007-04-03 | 2008-10-16 | Janssen Pharmaceutica N.V. | Aryl sulfonamide compounds as modulators of the cck2 receptor |
-
2010
- 2010-06-03 WO PCT/US2010/037200 patent/WO2010141680A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060132615A (en) * | 2003-12-15 | 2006-12-21 | 니뽄 다바코 산교 가부시키가이샤 | Cyclopropane compounds and pharmaceutical use thereof |
WO2008124524A2 (en) * | 2007-04-03 | 2008-10-16 | Janssen Pharmaceutica N.V. | Aryl sulfonamide compounds as modulators of the cck2 receptor |
Also Published As
Publication number | Publication date |
---|---|
WO2010141680A2 (en) | 2010-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012019427A8 (en) | Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof | |
IL219530A (en) | Substituted 4-aminocyclohexane compounds, medications comprising said compounds and their use for the production of medications | |
IL200603A0 (en) | Inhibitors of the hedgehog pathway | |
WO2009036175A3 (en) | F1f0-atpase inhibitors and related methods | |
IL205360A0 (en) | Methods, kits, and compositions for administering pharmaceutical compounds | |
EP2625377A4 (en) | Methods for completing multi-zone production wells using sliding sleeve valve assembly | |
WO2010060937A3 (en) | Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor | |
ZA201000106B (en) | Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases | |
ZA201000087B (en) | Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases | |
WO2008095086A3 (en) | Topiramate plus naltrexone for the treatment of addictive disorders | |
BRPI0816881A2 (en) | Compound, pharmaceutical composition, use of a compound, and methods for treating diseases or disorders and for preparing a compound. | |
EP2506712B8 (en) | Morphinan derivatives for the treatment of drug overdose | |
WO2012116010A3 (en) | Antibiotic tolerance inhibitors | |
WO2012078902A3 (en) | Proteostasis regulators | |
WO2010091197A3 (en) | Tablets for combination therapy | |
EP2058024A4 (en) | Medicine sprayer | |
WO2011009938A3 (en) | Stambomycin and derivatives, their production and their use as drugs | |
WO2009071689A3 (en) | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases | |
WO2011060363A3 (en) | Cyclohexyl urea modulators of d2 receptors and/or d3 receptors | |
ZA201103727B (en) | Sulfoximine-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as medicine | |
WO2012103810A1 (en) | Certain chemical entities, compositions, and methods | |
ZA200808754B (en) | Tetrahydronaphthaline derivatives, methods for the production and use hereof as anti-inflammatory agents | |
IL201449A0 (en) | Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases | |
IL201562A0 (en) | Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases | |
EP2164328B8 (en) | Therapeutic pyrazoloquinoline urea derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10784069 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10784069 Country of ref document: EP Kind code of ref document: A2 |